149 related articles for article (PubMed ID: 38004439)
1. Immunomodulatory, Antioxidant, and Anti-Inflammatory Activities of Green Synthesized Copper Nanoparticles for Treatment of Chronic
Alanazi AD; Alnomasy SF
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004439
[TBL] [Abstract][Full Text] [Related]
2. High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency.
Majeed QAH; Alnomasy SF; Shater AF; Alanazi AD
Acta Parasitol; 2024 Jun; 69(2):1201-1211. PubMed ID: 38634986
[TBL] [Abstract][Full Text] [Related]
3. The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.
Albalawi AE; Alanazi AD; Alyousif MS; Sepahvand A; Ebrahimi K; Niazi M; Mahmoudvand H
Acta Parasitol; 2021 Dec; 66(4):1472-1479. PubMed ID: 34050875
[TBL] [Abstract][Full Text] [Related]
4. The role of
Ezzatkhah F; Mahmoudvand H; Raziani Y
Front Cell Infect Microbiol; 2023; 13():1161133. PubMed ID: 37249978
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential and Safety of the
Alanazi AD; Almohammed HI
Front Cell Infect Microbiol; 2022; 12():900046. PubMed ID: 35755846
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of royal jelly to control Toxoplasma gondii infection in mice.
Althobaiti NA
Trop Biomed; 2022 Jun; 39(2):295-301. PubMed ID: 35838104
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo Anti-
Alnomasy SF
Infect Drug Resist; 2021; 14():5057-5068. PubMed ID: 34876824
[TBL] [Abstract][Full Text] [Related]
8. Green synthesis of zinc nanoparticles using
Saadatmand M; Al-Awsi GRL; Alanazi AD; Sepahvand A; Shakibaie M; Shojaee S; Mohammadi R; Mahmoudvand H
Saudi J Biol Sci; 2021 Nov; 28(11):6454-6460. PubMed ID: 34764762
[TBL] [Abstract][Full Text] [Related]
9. Potent In Vitro and In Vivo Effects of
Alanazi AD; Majeed QAH; Alnomasy SF; Almohammed HI
Trop Med Infect Dis; 2023 Jul; 8(7):. PubMed ID: 37505651
[TBL] [Abstract][Full Text] [Related]
10. Elettaria cardamomum essential oil; immunomodulatory, antioxidant, and anti-inflammatory effects for controlling acute Toxoplasma gondii infection.
Abdullah DA; Aishah EA
Trop Biomed; 2023 Dec; 40(4):453-461. PubMed ID: 38308833
[TBL] [Abstract][Full Text] [Related]
11. Effect of HIV aspartyl protease inhibitors on experimental infection with a cystogenic Me49 strain of
Abou-El-Naga IF; Gomaa MM; ElAchy SN
Pathog Glob Health; 2022 Mar; 116(2):107-118. PubMed ID: 34420500
[TBL] [Abstract][Full Text] [Related]
12. Immune-enhancing activity of
Behnam S; Kharazmkia A; Khalaf AK; Adineh A; Ghasemian Yadegari J; Mahmoudvand H
Ann Med Surg (Lond); 2023 Sep; 85(9):4342-4347. PubMed ID: 37663719
[TBL] [Abstract][Full Text] [Related]
13. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
14. Promising
Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
[TBL] [Abstract][Full Text] [Related]
15. Anti-toxoplasma and Cytotoxic Activities of Holothuria leucospilota Extract and TiO
Asadi N; Yousefi E; Tappeh KH; Khademvatan S
Infect Disord Drug Targets; 2022; 22(3):e170122200295. PubMed ID: 35078399
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Activity of Biogenic Selenium Nanoparticles Against Chronic
Keyhani A; Shakibaie M; Mahmoudvand H; Jahanbakhsh S; Kareshk AT; Shojaee S; Ziaali N
Recent Pat Antiinfect Drug Discov; 2020; 15(1):75-84. PubMed ID: 32496989
[TBL] [Abstract][Full Text] [Related]
18. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 70 is a potential virulence factor in murine toxoplasma infection via immunomodulation of host NF-kappa B and nitric oxide.
Dobbin CA; Smith NC; Johnson AM
J Immunol; 2002 Jul; 169(2):958-65. PubMed ID: 12097402
[TBL] [Abstract][Full Text] [Related]
20. Linalool-zinc oxide nanocomposite controls Toxoplasma gondii infection through inhibiting inflammation, oxidative stress, and pathogenicity.
Baghdadi HBA; Albalawi AE; Shater AF; Almohammed H; Alanazi AD
J Basic Microbiol; 2024 May; ():e202400039. PubMed ID: 38690754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
